Company: XAIR
Filing Date: 2025-06-20
Form Type: 10-K
Source: 0001641172-25-015750
Chunk: 1206

Company: Beyond Air, Inc.
Filing Date: 2025-06-20
Form: 10-K
Item: Item 2
Chunk 1206
---
 in salaries $1.5 million in Beyond Air,
stock-based compensation $4.0 million ($0.7 million
in Beyond Air and $3.3 million in Beyond Cancer), pre-clinical studies $1.1 million reduced spend in Beyond
Cancer on device development costs, clinical studies $1.9 million ($1.5 million
in Beyond Air and $0.4 million in Beyond Cancer), professional fees $1.0 million
($0.6 million in Beyond Air and $0.4 million
in Beyond Cancer) and travel expenses $0.2 million.

Selling, General and Administrative Expenses

Selling, general
and administrative expenses for the year ended March 31, 2025 and March 31, 2024 were $26.0
million and $37.3 million, respectively. The decrease of $11.3 million was attributed primarily to a decrease in spend in salaries
$1.8 million ($2.7 million in Beyond Air offset by an increase of $0.9 million in Beyond Cancer), $8.3 million due to stock based
compensation cost ($2.3 million in Beyond Air and $6.0 million in Beyond Cancer),
$0.6 million professional fees ($0.8 million in Beyond Air offset by increased spend $0.1 million in Beyond Cancer and $0.1 million
in NeuroNos), $0.3 million marketing and advertising costs for Beyond Air, $0.4 million rent costs ($0.2 million in Beyond Air and
$0.2 million in Beyond Cancer), $0.4 million travel costs ($0.3 million in Beyond Air and $0.1 million in Beyond Cancer) offset by
an increase in Beyond Air of $0.4 million in legal fees and $0.2 million in royalty payments.

Other Income and Expense

Other expenses for the year ended
March 31, 2025 and March 31, 2024, was $3.9 million and of $1.3 million, respectively. The $2.6 million increase in expense is mainly
due to a loss on the extinguishment of debt of $2.4 million, a decrease in interest and dividend income from our investments in marketable
securities of $1.0 million, a loss in disposal of fixed assets of $0.2 million, an impairment of fixed assets $0.5 million and a change
in the fair value of warrant liability of $